“Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s141. Accessed April 20, 2026. https://skin.dermsquared.com/skin/article/view/2024.